June

Two early-to-mid-career researchers have secured funding for globally significant vaccine research while the University of Sydney Institute for Infectious Diseases’ (Sydney ID) global leadership in tuberculosis helped to secure a grant from the United States’ National Institutes of Health (NIH), for $US3.1 million.